文献速递神经肿瘤

NEK6作为胶质瘤预后潜在生物标志物及其功能意义

Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications.
PubMed 文献 · J Neurooncol · 2025-12-10

本研究通过泛癌分析探索NEK6的预后价值与功能,发现NEK6在胶质瘤中显著上调且与不良临床预后相关。单细胞分析显示NEK6过表达与恶性细胞及单核/巨噬细胞高度相关,体外实验表明敲低NEK6可抑制胶质瘤细胞生长与迁移,导致G2/M期阻滞并触发凋亡。

要点

  • NEK6在胶质瘤中显著上调,其升高与患者不良临床预后相关。
  • 单细胞分析显示NEK6过表达与恶性细胞及单核/巨噬细胞高度相关。
  • 敲低NEK6抑制胶质瘤细胞生长与迁移,引起G2/M期阻滞并触发凋亡。

核心结论

  • NEK6在胶质瘤中具有预后价值、治疗潜力及分子机制意义。

研究设计与样本

  • 研究对NEK6进行泛癌综合分析,包括表达谱、免疫特征及其与临床预后的关系。
  • 通过多种细胞实验(克隆形成实验、MTT实验和流式细胞术)及基于临床样本的分析(如免疫组化分析)验证主要结论。

主要发现

  • NEK6在胶质瘤中显著上调,其水平升高与患者不良临床预后相关。
  • 单细胞分析显示NEK6过表达与胶质瘤组织中的恶性细胞及单核/巨噬细胞高度相关。
  • NEK6减少阻碍胶质瘤细胞的生长和迁移能力,导致细胞周期停滞于G2/M期并触发凋亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Never in mitosis gene A-related kinase 6 (NEK6) is involved in mitotic cell cycle. The objective of the present study is to comprehensively explore the prognostic value of NEK6 and its potential functions in multiple cancers, especially in gliomas. METHODS: We performed comprehensive analyses of NEK6 in pan-cancer, including expression profile, immune characteristics and its relationship with clinical prognosis. Moreover, we validated our significant conclusions through multiple cell experiments (such as clone formation assay, MTT assay and flow cytometry) and analyses based on clinical samples (such as immunohistochemistry analysis). RESULTS: NEK6 was significantly upregulated in gliomas. And our study indicated that the increased level of NEK6 was associated with poor clinical prognoses of patients. The single-cell analysis revealed that NEK6 overexpression was highly related to malignant cells and Mono/Macrophages (denoted as the monocyte and macrophage population) in glioma tissue. The decrease in NEK6 hindered the growth and migration capacity of the glioma cells, leading to a halt in the G2/M phase of the cell cycle and triggering apoptosis. CONCLUSION: Taken together, our data uncovered the prognostic value, therapeutic potential, and molecular insight of NEK6 in glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wang D, Wang Z, Xu J, et al. Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications. J Neurooncol. 2025. PMID: 41369743. doi:10.1007/s11060-025-05260-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。